Emerging Antimicrobial Resistance Patterns among Uropathogens in Baghdad
Article Sidebar
Antimicrobial Resistance,
Escherichia Coli
Main Article Content
Abstract
Urinary tract infections (UTIs) are a common bacterial illness worldwide, but rising antimicrobial resistance (AMR) poses a therapeutic issue. Iraq lacks current local data on UTI-causing pathogens and their resistance patterns. The aim of this research is to examine the progression of uropathogens isolated from urine samples in Baghdad and assess their antibiotic susceptibility profiles. Between May 2023 and December 2024 in Baghdad gathered a total of 163 urine samples. Standard microbiological techniques were used to identify isolates, and antimicrobial susceptibility testing was carried out in accordance with CLSI guidelines. Escherichia coli was the most common isolate (64.4%), followed by Klebsiella pneumoniae (14.1%), Enterococcus faecalis (11.0%), and Pseudomonas aeruginosa (9.2%). Beta-lactams and fluoroquinolones showed high resistance, although carbapenems and Amikacin were still effective. There was no statistically significant relationship detected between gender and pathogen type (p > 0.05). The data reveal the worrying levels of resistance to common uropathogens in Baghdad, emphasizing the importance of culture-based treatment and national AMR surveillance.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Al-Badr, A., & Al-Shaikh, G. (2013). Recurrent urinary tract infections management in women: A review. Saudi Medical Journal, 34(1), 29–34.
Al-Hasan, M. N., Eckel-Passow, J. E., & Baddour, L. M. (2014). Bacteremia complicating Gram-negative urinary tract infections: A population-based study. International Journal of Infectious Diseases, 68(4), 289–295. https://doi.org/10.1016/j.ijid.2013.09.009
Al-Jebouri, M. M., & Al-Daamy, A. A. (2013). Antibiotic resistance patterns of uropathogenic bacteria isolated from urinary tract infections in Iraq. Journal of Infection in Developing Countries, 7(5), 366–373. https://doi.org/10.3855/jidc.2642
Al-Tamimi, M., Himsawi, N., Al-Masri, M., & Issa, R. (2018). Prevalence and antimicrobial resistance of uropathogens from community-acquired urinary tract infections in Palestine. Eastern Mediterranean Health Journal, 24(1), 67–75. https://doi.org/10.26719/2018.24.1.67
Bush, K., Courvalin, P., Dantas, G., Davies, J., Eisenstein, B., Huovinen, P., ... & Jacoby, G. A. (2020). Tackling antibiotic resistance. Nature Reviews Microbiology, 9(12), 894–896. https://doi.org/10.1038/nrmicro2677
Clinical and Laboratory Standards Institute. (2024). Performance standards for antimicrobial susceptibility testing (CLSI M100). CLSI.
El-Kholy, A., Baseem, H., Hall, G. S., Procop, G. W., & Longworth, D. L. (2021). Antimicrobial resistance in pathogens causing urinary tract infections in Egypt: A multicenter study. BMC Infectious Diseases, 21, 103. https://doi.org/10.1186/s12879-020-05705-9
European Centre for Disease Prevention and Control, & World Health Organization. (2023). Antimicrobial resistance surveillance in Europe: Annual report 2023. https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2023
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015). Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology, 13(5), 269–284. https://doi.org/10.1038/nrmicro3432
Foxman, B. (2010). The epidemiology of urinary tract infection. Nature Reviews Urology, 7(12), 653–660. https://doi.org/10.1038/nrurol.2010.190
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., ... & Soper, D. E. (2011). International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update. Clinical Infectious Diseases, 52(5), e103–e120. https://doi.org/10.1093/cid/ciq257
Ibrahim, M. E., Bilal, N. E., Hamid, M. E., & Elamin, B. K. (2019). Multidrug-resistant uropathogens in the Middle East: A growing concern. Journal of Global Antimicrobial Resistance, 17, 48–53. https://doi.org/10.1016/j.jgar.2018.11.019
Kahlmeter, G. (2019). The ECO·SENS project: A prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens—Interim report. Journal of Antimicrobial Chemotherapy, 44(Suppl 1), 15–22. https://doi.org/10.1093/jac/44.suppl_1.15
Karam, R. A., Tawfik, A. F., & Ashour, H. M. (2022). Multidrug-resistant uropathogens: A worldwide threat with regional variability. International Journal of Environmental Research and Public Health, 19(12), 7405. https://doi.org/10.3390/ijerph19127405
Livermore, D. M. (2004). The need for new antibiotics. Clinical Microbiology and Infection, 10(s4), 1–9. https://doi.org/10.1111/j.1469-0691.2004.1004.x
Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., ... & Monnet, D. L. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions. Clinical Microbiology and Infection, 18(3), 268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., ... & Klugman, K. P. (2005). Antimicrobial resistance in developing countries. Part I: Recent trends and current status. The Lancet Infectious Diseases, 5(8), 481–493. https://doi.org/10.1016/S1473-3099(05)70189-4
Tängdén, T., & Giske, C. G. (2015). Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: Clinical perspectives on detection, treatment and infection control. International Journal of Antimicrobial Agents, 45(1), 1–10. https://doi.org/10.1016/j.ijantimicag.2014.10.002
World Health Organization. (2023). Antimicrobial resistance: Key facts. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
Zowawi, H. M., Harris, P. N., Roberts, M. J., Tambyah, P. A., Schembri, M. A., Pezzani, M. D., ... & Paterson, D. L. (2020). The emerging threat of multidrug-resistant Gram-negative bacteria in urology. The Lancet Infectious Diseases, 20(9), e147–e159. https://doi.org/10.1016/S1473-3099(20)30064-4